Tissue Specific Differentiation of Human Chondrocytes Depends on Cell Microenvironment and Serum Selection.

Therapeutic options to cure osteoarthritis (OA) are not yet available, although cell-based therapies for the treatment of traumatic defects of cartilage have already been developed using, e.g., articular chondrocytes.